The preventive effect of berberis vulgaris extract on contrast-induced acute kidney injury

Journal of Nephropathology

Volumn 6, Issue 4, 2017, Pages 395-398

  Asgharian, Shirin ^a   Lorigooini, Zahra ^a   Rafieian, Reza ^a   Rafieian Kopaei, Mahmoud ^a   Kheiri, Soleiman ^a   Nasri, Hamid ^b  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Berberis vulgaris; Contrast; Kidney injury; Rat

Indexed keywords

BERBERIS VULGARIS EXTRACT; BEROLINE; BISBENZYLISOQUINOLINE ALKALOID; INOSITOL; OXYGEN RADICAL; PLANT EXTRACT; PROTOBERBERINE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BERBERIS VULGARIS; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; NONHUMAN; RAT; TISSUE INJURY;

EID: 85046550513     PISSN: 22518363     EISSN: 22518819     Source Type: Journal    
DOI: 10.15171/jnp.2017.65     Document Type: Article

References (27)

1. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy. Circulation. 2006;113(14):1799-806.
2. Maliborski A, Żukowski P, Nowicki G, Bogusławska R. Contrast-induced nephropathy–a review of current literature and guidelines. Medical Science Monitor. 2011;17(9):RA199-RA204.
3. Nasri H, Tavakoli M, Ahmadi A, Baradaran A, Nematbakhsh M, Rafieian-Kopaei M. Ameliorative effect of melatonin against contrast media induced renal tubular cell injury. Pak J Med Sci. 2014;30(2):261-5.
4. McDonald RJ, McDonald JS, Bida JP, Carter RE, Fleming CJ, Misra S, et al. Intravenous contrast material–induced nephropathy: causal or coincident phenomenon? Radiology. 2013;267(1):106-18.
5. Sanadgol H, Abdani S, Tabatabaiee P, Mohammadi M. Protective effect of high dose short term statin therapy with normal saline in prevention of contrast-induced nephropathy among iodixanol-receiving patients. J Renal Inj Prev. 2012;1(1):43.
6. Kwok C, Pang C, Yeong J, Loke Y. Measures used to treat contrast-induced nephropathy: overview of reviews. Br J Radiol. 2013;86(1021):20120272. doi: 10.1259/bjr.20120272.
7. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;(100):S11-5.
8. El-Wahab AEA, Ghareeb DA, Sarhan EE, Abu-Serie MM, El Demellawy MA. In vitro biological assessment of Berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. BMC Complement Altern Med. 2013;13:218. doi: 10.1186/1472-6882-13-218.
9. Shirzad H, Taji F, Rafieian-Kopaei M. Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice. J Med Food. 2011;14(9):969-74.
10. Rafieian-Kopaei M, Baradaran A, Rafieian M. Plants antioxidants: From laboratory to clinic. J Nephropathol. 2013;2(2):152-3. doi: 10.12860/JNP.2013.26.
11. Rafieian-Kopaei M. Medicinal plants and the human needs. J HerbMed Pharmacol. 2012;1(1):1–2.
12. Nickavar B, Abolhasani FA. Screening of antioxidant properties of seven Umbelliferae fruits from Iran. Pak J Pharm Sci. 2009;22(1):30-5.
13. Dastmalchi K, Dorman HD, Koşar M, Hiltunen R. Chemical composition and in vitro antioxidant evaluation of a water-soluble Moldavian balm (Dracocephalum moldavica L.) extract. LWT-Food Science and Technology. 2007;40(2):239-48.
14. Hanachi P, Golkho S. Using HPLC to determination the composition and antioxidant activity of Berberis vulgaris. Eur J Sci Res. 2009;29(1):47-54.
15. Zargari A. Medicinal Plants. Tehran: Tehran University Publications.; 1995.
16. Hoshyar R, Mahboob Z, Zarban A. The antioxidant and chemical properties of Berberis vulgaris and its cytotoxic effect on human breast carcinoma cells. Cytotechnology. 2016;68(4):1207-13.
17. Fatehi M, Saleh TM, Fatehi-Hassanabad Z, Farrokhfal K, Jafarzadeh M, Davodi S. A pharmacological study on Berberis vulgaris fruit extract. J Ethnophar macol.2005;102(1):46-52.
18. Ivanovska N, Philipov S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol. 1996;18(10):553-61.
19. Heidarian E, Rafieian-Kopaei M. Protective effect of artichoke (Cynara scolymus) leaf extract against lead toxicity in rat. Pharm Biol. 2013;51(9):1104-9. doi: 10.3109/13880209.2013.777931.
20. Wong PCY, Li Z, Guo J, Zhang A. Pathophysiology of contrast-induced nephropathy. Int J Cardiol. 2012;158(2):186-92.
21. Jyothilakshmi V, Thellamudhu G, Chinta R, Alok K, Anil K, Debadatta N, et al. Beneficial antioxidative effect of the homeopathic preparation of Berberis vulgaris in alleviating oxidative stress in experimental urolithiasis. Forsch Komplementmed. 2014;21(1):7-12.
22. Laamech J, El-Hilaly J, Fetoui H, Chtourou Y, Tahraoui A, Lyoussi B. Nephroprotective effects of Berberis vulgaris L. total extract on lead acetate-induced toxicity in mice. Indian J Pharm Sci.2016;78(3):326-33.
23. Changizi Ashtiyani S, Seddigh A, Najafi H, Hossaini N, Avan A, Akbary A, et al. Pimpinella anisum L. ethanolic extract ameliorates the gentamicin‐induced nephrotoxicity in rats. Nephrology. 2017;22(2):133-8.
24. Abdel-Raheem IT, Abdel-Ghany AA, Mohamed GA. Protective effect of quercetin against gentamicin-induced nephrotoxicity in rats. Biol Pharm Bull. 2009;32(1):61-7.
25. Otunctemur A, Ozbek E, Dursun M, Sahin S, Besiroglu H, Ozsoy OD, et al. Protective effect of hydrogen sulfide on gentamicin-induced renal injury. Ren Fail. 2014;36(6):925-31.
26. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Di Paola R, Britti D, et al. A role for superoxide in gentamicin-mediated nephropathy in rats. Eur J Pharmacol. 2002;450(1):67-76.
27. Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology. 2005;212(2):116-23.